Embella (Deoxycholic acid, produced by Espad Pharmed Co.)

DEVICE2 trials

Sponsors

Espad Pharmed

Conditions

LipomaSubmental Fullness

Unknown Phase

Effectiveness and Safety Evaluation of Embella (Deoxycholic Acid, by Espad Pharmed Co.) in Management of Submental Fat

CompletedNCT06509438

Espad PharmedSubmental Fullness

Start: 2023-04-10End: 2024-01-01Updated: 2025-09-19

Evaluating the Efficacy and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) Injection in the Management of Superficial Lipomas

RecruitingNCT07014163

Espad PharmedLipoma

Start: 2024-05-21End: 2026-06-20Target: 10Updated: 2025-06-10